Invention Grant
- Patent Title: Controlled activation ingestible identifier
- Patent Title (中): 受控活化可摄取标识符
-
Application No.: US12447172Application Date: 2007-10-25
-
Publication No.: US08945005B2Publication Date: 2015-02-03
- Inventor: Hooman Hafezi , Timothy Robertson , Olivier Colliou , Mark Zdeblick
- Applicant: Hooman Hafezi , Timothy Robertson , Olivier Colliou , Mark Zdeblick
- Applicant Address: US CA Redwood City
- Assignee: Proteus Digital Health, Inc.
- Current Assignee: Proteus Digital Health, Inc.
- Current Assignee Address: US CA Redwood City
- Agency: K&L Gates LLP
- International Application: PCT/US2007/082563 WO 20071025
- International Announcement: WO2008/052136 WO 20080502
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61P43/00 ; H01M6/32 ; A61K49/00 ; H01M10/04 ; A61B5/07 ; A61B5/145 ; A61B5/1473 ; A61B5/00 ; H01M10/00 ; A61J3/00
Abstract:
Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
Public/Granted literature
- US20100239616A1 CONTROLLED ACTIVATION INGESTIBLE IDENTIFIER Public/Granted day:2010-09-23
Information query
